Clinical Trials Directory

Trials / Unknown

UnknownNCT02541110

Prediction of Preeclampsia & Other Obstetric Complications by Serum Homocysteine & Doppler

Second Trimester Maternal Serum Homocysteine Level & Uterine Artery Doppler for Prediction of Preeclampsia , Intra-Uterine Growth Retardation (IUGR) & Other Obstetric Complications

Status
Unknown
Phase
Study type
Observational
Enrollment
200 (estimated)
Sponsor
Kasr El Aini Hospital · Academic / Other
Sex
Female
Age
18 Years – 40 Years
Healthy volunteers
Accepted

Summary

Second trimester homocysteine \& uterine artery doppler will be assessed\& the cases will be followed up till delivery for development of preeclampsia, IUGR(intra-uterine growth retardation) \& other obstetric complications.

Detailed description

Spontaneous pregnancies with no risk factors will be included. Fasting plasma total homocysteine level samples will be collected between 15th \& 19th weeks. Uterine artery doppler between 18th \& 22nd weeks. Method 1: Screen positive cases will be considered if homocysteine level above 6.3umol/l Method 2: Screen positive cases will be considered if they had bilateral notches and a mean resistivity index (RI) above 0.55, or unilateral notches and a mean RI above 0.65, or absence of notches and a mean RI above 0.7. Method 3: Screen positive cases will be considered if they had bilateral notches and a mean RI above 0.55, or unilateral notches and a mean RI above 0.65, or absence of notches and a mean RI above 0.7 combined with homocysteine cut off value of 6.3umol / l.

Conditions

Timeline

Start date
2015-09-01
Primary completion
2016-01-01
Completion
2016-02-01
First posted
2015-09-04
Last updated
2015-09-04

Source: ClinicalTrials.gov record NCT02541110. Inclusion in this directory is not an endorsement.